Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Chugai Pharmaceutical Co ( (JP:4519) ).
Chugai Pharmaceutical Co. reported a 5% increase in revenue for the nine months ending September 30, 2025, with operating profit and net income also seeing modest growth. The company announced a special dividend to mark its 100th anniversary, reflecting strong financial performance and a commitment to rewarding shareholders. The forecast for the full year 2025 remains positive, with expectations of continued revenue and profit growth.
The most recent analyst rating on (JP:4519) stock is a Buy with a Yen8050.00 price target. To see the full list of analyst forecasts on Chugai Pharmaceutical Co stock, see the JP:4519 Stock Forecast page.
More about Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd. is a leading company in the pharmaceutical industry, primarily focused on the development and distribution of innovative medical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to advancing healthcare solutions.
Average Trading Volume: 3,630,291
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen11884.7B
Learn more about 4519 stock on TipRanks’ Stock Analysis page.